{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:18:56Z","timestamp":1790245136203,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.tiv.2026.106290","type":"journal-article","created":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T19:44:47Z","timestamp":1785699887000},"page":"106290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A targeted lipidomics workflow for high-throughput phenotyping and mechanism-based in vitro hepatotoxicity studies"],"prefix":"10.1016","volume":"117","author":[{"given":"Tzu-Hsin","family":"Yen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chander K.","family":"Negi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Sakolish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin S.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Rusyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2026.106290_bb0005","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1021\/acs.jproteome.9b00640","article-title":"Skyline for small molecules: a unifying software package for quantitative metabolomics","volume":"19","author":"Adams","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.tiv.2026.106290_bb0010","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0024-3205(86)90083-4","article-title":"Modifications of sphingomyelin and phosphatidylcholine metabolism by tricyclic antidepressants and phenothiazines","volume":"38","author":"Albouz","year":"1986","journal-title":"Life Sci."},{"key":"10.1016\/j.tiv.2026.106290_bb0015","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1194\/jlr.M079012","article-title":"Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using SRM 1950-metabolites in frozen human plasma","volume":"58","author":"Bowden","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tiv.2026.106290_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-84268-9","article-title":"Lipotoxic stress alters the membrane lipid profile of extracellular vesicles released by Huh-7 hepatocarcinoma cells","volume":"11","author":"Buratta","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tiv.2026.106290_bb0025","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1194\/jlr.S087163","article-title":"MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines","volume":"59","author":"Burla","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tiv.2026.106290_bb0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.aca.2017.03.033","article-title":"Using precursor ion scan of 184 with liquid chromatography-electrospray ionization-tandem mass spectrometry for concentration normalization in cellular lipidomic studies","volume":"971","author":"Chao","year":"2017","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.tiv.2026.106290_bb0035","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.tibs.2025.01.007","article-title":"Decoding ceramide function: how localization shapes cellular fate and how to study it","volume":"50","author":"Chitkara","year":"2025","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.tiv.2026.106290_bb0040","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1042\/EBC20200067","article-title":"Mammalian lipids: structure, synthesis and function","volume":"65","author":"Cockcroft","year":"2021","journal-title":"Essays Biochem."},{"key":"10.1016\/j.tiv.2026.106290_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114666","article-title":"Untargeted liquid chromatography-mass spectrometry metabolomics to assess drug-induced cholestatic features in HepaRG\u00ae cells","volume":"379","author":"Cuykx","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2026.106290_bb0050","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s13238-017-0423-5","article-title":"Structural and functional roles of ether lipids","volume":"9","author":"Dean","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.tiv.2026.106290_bb0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-3-319-48382-5_8","article-title":"What is lipotoxicity?","volume":"960","author":"Engin","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.tiv.2026.106290_bb0060","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1067\/mcp.2001.114667","article-title":"The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions","volume":"69","author":"Fattinger","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2026.106290_bb0065","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00204-019-02427-4","article-title":"Integrated in vitro models for hepatic safety and metabolism: evaluation of a human liver-chip and liver spheroid","volume":"93","author":"Foster","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2026.106290_bb0070","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10495-009-0449-0","article-title":"Ceramide and activated Bax act synergistically to permeabilize the mitochondrial outer membrane","volume":"15","author":"Ganesan","year":"2010","journal-title":"Apoptosis"},{"key":"10.1016\/j.tiv.2026.106290_bb0075","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.28022.1","article-title":"BioPAN: a web-based tool to explore mammalian lipidome metabolic pathways on LIPID MAPS","volume":"10","author":"Gaud","year":"2021","journal-title":"F1000Res"},{"key":"10.1016\/j.tiv.2026.106290_bb0080","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00204-013-1078-5","article-title":"Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME","volume":"87","author":"Godoy","year":"2013","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2026.106290_bb0085","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tox.2009.08.007","article-title":"Cell based approaches for evaluation of drug-induced liver injury","volume":"268","author":"Greer","year":"2010","journal-title":"Toxicology"},{"key":"10.1016\/j.tiv.2026.106290_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10040792","article-title":"Roles of ceramides in non-alcoholic fatty liver disease","volume":"10","author":"Hajduch","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.tiv.2026.106290_bb0095","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrm.2017.138","article-title":"Understanding the diversity of membrane lipid composition","volume":"19","author":"Harayama","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tiv.2026.106290_bb0100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cotox.2019.05.004","article-title":"Considerations for strategic use of high-throughput transcriptomics chemical screening data in regulatory decisions","volume":"15","author":"Harrill","year":"2019","journal-title":"Curr. Opin. Toxicol."},{"key":"10.1016\/j.tiv.2026.106290_bb0105","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/toxsci\/kfz195","article-title":"Mechanisms of chronic Fialuridine hepatotoxicity as revealed in primary human hepatocyte spheroids","volume":"171","author":"Hendriks","year":"2019","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2026.106290_bb0110","article-title":"Industry adoption of organoids and organs-on-chip technology: toward a paradox of choice","volume":"7","author":"Homan","year":"2023","journal-title":"Adv. Biol. (Weinh)"},{"key":"10.1016\/j.tiv.2026.106290_bb0115","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1038\/s42255-023-00880-1","article-title":"Dynamic lipidome alterations associated with human health, disease and ageing","volume":"5","author":"Hornburg","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.tiv.2026.106290_bb0120","first-page":"489","article-title":"Comprehensive targeted lipidomic profiling for research and clinical applications","volume":"2628","author":"Huynh","year":"2023","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.tiv.2026.106290_bb0125","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12944-015-0104-4","article-title":"Comparison of circulating lipid profiles between fasting humans and three animal species used in preclinical studies: mice, rats and rabbits","volume":"14","author":"Ishikawa","year":"2015","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.tiv.2026.106290_bb0130","doi-asserted-by":"crossref","first-page":"15893","DOI":"10.1038\/s41598-018-34329-3","article-title":"Plasma lipidomic analysis reveals strong similarities between lipid fingerprints in human, hamster and mouse compared to other animal species","volume":"8","author":"Kaabia","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tiv.2026.106290_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124501","article-title":"An updated review of pro- and anti-inflammatory properties of plasma Lysophosphatidylcholines in the vascular system","volume":"21","author":"Knuplez","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tiv.2026.106290_bb0140","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12944-020-01286-8","article-title":"Diacylglycerol-evoked activation of PKC and PKD isoforms in regulation of glucose and lipid metabolism: a review","volume":"19","author":"Kolczynska","year":"2020","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.tiv.2026.106290_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100621","article-title":"The lipidomics reporting checklist a framework for transparency of lipidomic experiments and repurposing resource data","volume":"65","author":"Kopczynski","year":"2024","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tiv.2026.106290_bb0150","first-page":"4501","article-title":"An updated review of Lysophosphatidylcholine metabolism in human diseases","volume":"21","author":"Law","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tiv.2026.106290_bb0155","doi-asserted-by":"crossref","first-page":"16902","DOI":"10.1021\/acs.analchem.3c02693","article-title":"Differentiation of alkyl- and Plasmenyl-phosphatidylcholine by endogenous sphingomyelin RT-XLOGP3 regression for coronary artery disease plasma lipidomics analysis","volume":"95","author":"Lee","year":"2023","journal-title":"Anal. Chem."},{"key":"10.1016\/j.tiv.2026.106290_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/cem.3636","article-title":"Normalization strategies for lipidome data in cell line panels","volume":"39","author":"Leegwater","year":"2025","journal-title":"J. Chemom."},{"key":"10.1016\/j.tiv.2026.106290_bb0165","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1073\/pnas.93.8.3592","article-title":"Fialuridine and its metabolites inhibit DNA polymerase gamma at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts","volume":"93","author":"Lewis","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tiv.2026.106290_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2020.106484","article-title":"Sphingolipid metabolism as a marker of hepatotoxicity in drug-induced liver injury","volume":"151","author":"Li","year":"2020","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.tiv.2026.106290_bb0175","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1073\/pnas.0630588100","article-title":"Triglyceride accumulation protects against fatty acid-induced lipotoxicity","volume":"100","author":"Listenberger","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tiv.2026.106290_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117443","article-title":"The mechanisms of lysophosphatidylcholine in the development of diseases","volume":"247","author":"Liu","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.tiv.2026.106290_bb0185","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1139\/cjpp-2012-0223","article-title":"Molecular cytotoxic mechanisms of chlorpromazine in isolated rat hepatocytes","volume":"91","author":"MacAllister","year":"2013","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.tiv.2026.106290_bb0190","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1742-4658.2010.07972.x","article-title":"Interruption of triacylglycerol synthesis in the endoplasmic reticulum is the initiating event for saturated fatty acid-induced lipotoxicity in liver cells","volume":"278","author":"Mantzaris","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.tiv.2026.106290_bb0195","first-page":"365","article-title":"Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development","volume":"37","author":"Marx","year":"2020","journal-title":"ALTEX"},{"key":"10.1016\/j.tiv.2026.106290_bb0200","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJM199510263331702","article-title":"Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B","volume":"333","author":"McKenzie","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tiv.2026.106290_bb0205","doi-asserted-by":"crossref","first-page":"9564","DOI":"10.1021\/acs.analchem.5c04984","article-title":"A clinical lipidomics platform: development and validation of a high-throughput LC-MS assay for cardiovascular disease risk assessment","volume":"98","author":"Meikle","year":"2026","journal-title":"Anal. Chem."},{"key":"10.1016\/j.tiv.2026.106290_bb0210","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.70047","article-title":"Melatonin repairs the lipidome of human hepatocytes exposed to cd and free fatty acid-induced lipotoxicity","volume":"77","author":"Migni","year":"2025","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.tiv.2026.106290_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2026.101380","article-title":"Nutrigenomics of fat-soluble vitamins and micronutrients in hepatocyte lipotoxicity and MASLD","volume":"101","author":"Migni","year":"2026","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.tiv.2026.106290_bb0220","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41556-024-01377-z","article-title":"A lipid atlas of human and mouse immune cells provides insights into ferroptosis susceptibility","volume":"26","author":"Morgan","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tiv.2026.106290_bb0225","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41586-023-06857-0","article-title":"Mitochondrial dysfunction abrogates dietary lipid processing in enterocytes","volume":"625","author":"Moschandrea","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.tiv.2026.106290_bb0230","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1021\/acs.est.2c03998","article-title":"Replacement flame-retardant 2-ethylhexyldiphenyl phosphate (EHDPP) disrupts hepatic lipidome: evidence from human 3D hepatospheroid cell culture","volume":"57","author":"Negi","year":"2023","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.tiv.2026.106290_bb0235","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1021\/acs.chemrestox.5c00030","article-title":"2-Ethylhexyl diphenyl phosphate affects steroidogenesis and lipidome profile in human adrenal (H295R) cells","volume":"38","author":"Negi","year":"2025","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tiv.2026.106290_bb0240","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1021\/acsptsci.5c00554","article-title":"Comparative analysis of species-specific hepatocyte function and drug effects in a liver microphysiological system physiomimix LC12 and 96-well plates","volume":"8","author":"Negi","year":"2025","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.tiv.2026.106290_bb0245","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13024-023-00620-9","article-title":"Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer\u2019s disease drug candidate","volume":"18","author":"Nemergut","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tiv.2026.106290_bb0250","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jhep.2021.04.013","article-title":"Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis","volume":"75","author":"Ooi","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tiv.2026.106290_bb0255","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3897\/folmed.64.e59297","article-title":"Lysophospholipid metabolism and signalling in non-alcoholic fatty liver disease","volume":"64","author":"Papadopoulos","year":"2022","journal-title":"Folia Med."},{"key":"10.1016\/j.tiv.2026.106290_bb0260","doi-asserted-by":"crossref","first-page":"465","DOI":"10.4062\/biomolther.2021.107","article-title":"Bioactive lipids and their derivatives in biomedical applications","volume":"29","author":"Park","year":"2021","journal-title":"Biomol. Ther. (Seoul)"},{"key":"10.1016\/j.tiv.2026.106290_bb0265","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41573-022-00633-x","article-title":"The evolving role of investigative toxicology in the pharmaceutical industry","volume":"22","author":"Pognan","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tiv.2026.106290_bb0270","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1038\/s41556-025-01795-7","article-title":"Multi-omics identify hallmark protein and lipid features of small extracellular vesicles circulating in human plasma","volume":"27","author":"Rai","year":"2025","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tiv.2026.106290_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2024.117940","article-title":"Tips and tricks for LC-MS-based metabolomics and lipidomics analysis","volume":"180","author":"Rakusanova","year":"2024","journal-title":"Trac-Trends Anal. Chem."},{"key":"10.1016\/j.tiv.2026.106290_bb0280","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/s41467-020-15684-0","article-title":"Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance","volume":"11","author":"Roumans","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tiv.2026.106290_bb0285","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1002\/hep.31999","article-title":"Key characteristics of human hepatotoxicants as a basis for identification and characterization of the causes of liver toxicity","volume":"74","author":"Rusyn","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2026.106290_bb0290","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.bbalip.2014.01.009","article-title":"Chemical modulation of glycerolipid signaling and metabolic pathways","volume":"1841","author":"Scott","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tiv.2026.106290_bb0295","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbalip.2012.07.019","article-title":"Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)\/LPC and ATX\/LPA axes","volume":"1831","author":"Sevastou","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tiv.2026.106290_bb0300","article-title":"The promise of animal testing alternatives at the U.S. Food and Drug Administration and National Institutes of Health","volume":"3","author":"Tieghi","year":"2025","journal-title":"NEJM AI"},{"key":"10.1016\/j.tiv.2026.106290_bb0305","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/toxsci\/kfad041","article-title":"A tiered testing strategy based on in vitro phenotypic and transcriptomic data for selecting representative petroleum UVCBs for toxicity evaluation in vivo","volume":"193","author":"Tsai","year":"2023","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2026.106290_bb0310","series-title":"Roadmap to Reducing Animal Testing in Preclinical Safety Studies, Washington, DC","author":"US FDA","year":"2025"},{"key":"10.1016\/j.tiv.2026.106290_bb0315","series-title":"General Considerations for the Use of New Approach Methodologies in Drug Development (March 2026 Draft Guidance)","author":"US FDA","year":"2026"},{"key":"10.1016\/j.tiv.2026.106290_bb0320","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","article-title":"The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease","volume":"1859","author":"van der Veen","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.tiv.2026.106290_bb0325","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1021\/acs.chemrestox.5b00208","article-title":"Adverse outcome pathways and drug-induced liver injury testing","volume":"28","author":"Vinken","year":"2015","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tiv.2026.106290_bb0330","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/hep4.1302","article-title":"Impaired hepatic phosphatidylcholine synthesis leads to cholestasis in mice challenged with a high-fat diet","volume":"3","author":"Wan","year":"2019","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.tiv.2026.106290_bb0335","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nprot.2012.135","article-title":"Global metabolic profiling of animal and human tissues via UPLC-MS","volume":"8","author":"Want","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.tiv.2026.106290_bb0340","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41573-019-0048-x","article-title":"Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models","volume":"19","author":"Weaver","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tiv.2026.106290_bb0345","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.aeb0045","article-title":"Reimagining human-centric drug development with new approach methodologies","volume":"392","author":"Wu","year":"2026","journal-title":"Science"},{"key":"10.1016\/j.tiv.2026.106290_bb0350","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/metabo1010021","article-title":"Accurate quantification of lipid species by electrospray ionization mass spectrometry - meet a key challenge in lipidomics","volume":"1","author":"Yang","year":"2011","journal-title":"Metabolites"},{"key":"10.1016\/j.tiv.2026.106290_bb0355","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1016\/j.molcel.2021.08.027","article-title":"Lipid metabolism in sickness and in health: emerging regulators of lipotoxicity","volume":"81","author":"Yoon","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tiv.2026.106290_bb0360","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adx2681","article-title":"Targeted inhibition of hepatic de novo ceramide synthesis ameliorates MASH","volume":"11","author":"Yu","year":"2025","journal-title":"Sci. Adv."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233326000986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233326000986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:35:10Z","timestamp":1788348910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233326000986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":72,"alternative-id":["S0887233326000986"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2026.106290","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A targeted lipidomics workflow for high-throughput phenotyping and mechanism-based in vitro hepatotoxicity studies","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2026.106290","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106290"}}